DE69535592T2
(de)
|
1994-03-25 |
2008-06-12 |
Isotechnika, Inc., Edmonton |
Verbesserung der effektivität von arzneimitteln duren deuterierung
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
US5886022A
(en)
|
1995-06-05 |
1999-03-23 |
Bayer Corporation |
Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors
|
SI9600371B
(sl)
|
1996-12-18 |
2005-04-30 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Etilidenski derivati tricikličnih karbapenemov
|
US6300341B1
(en)
|
1998-09-30 |
2001-10-09 |
The Procter & Gamble Co. |
2-substituted heterocyclic sulfonamides
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
WO2003037894A1
(en)
|
2001-11-02 |
2003-05-08 |
Glaxo Group Limited |
4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
|
EP1440069B1
(en)
|
2001-11-02 |
2007-08-15 |
Glaxo Group Limited |
4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
|
NZ537214A
(en)
|
2002-07-05 |
2007-08-31 |
Targacept Inc |
N-Aryl diazaspiracyclic compounds capable of affecting nicotinic cholinergic receptors and methods of preparation and use thereof
|
JP2007527389A
(ja)
|
2003-06-30 |
2007-09-27 |
メルク エンド カムパニー インコーポレーテッド |
放射性カンナビノイド−1受容体修飾因子
|
FR2860431A1
(fr)
|
2003-10-02 |
2005-04-08 |
Oreal |
Composition capillaire ou de mascara contenant un compose azoique, son utilisation pour stimuler ou induire la pousse des cheveux ou des cils et/ou freiner leur chute
|
RU2006121990A
(ru)
|
2003-11-21 |
2007-12-27 |
Эррэй Биофарма Инк. (Us) |
Ингибиторы протеинкиназ акт
|
WO2005087765A1
(en)
|
2004-03-04 |
2005-09-22 |
Arena Pharmaceuticals, Inc. |
Ligands of follicle stimulating hormone receptor and methods of use thereof
|
BRPI0509576A
(pt)
|
2004-04-02 |
2007-05-29 |
Osi Pharm Inc |
composto, método de tratamento de um paciente tendo uma condição que é mediada pela atividade de proteìna quinase, e, composição farmacêutica
|
CN1972945A
(zh)
|
2004-04-02 |
2007-05-30 |
腺苷治疗有限责任公司 |
A2a腺苷受体的选择性拮抗剂
|
JP2008510711A
(ja)
|
2004-08-20 |
2008-04-10 |
ターガセプト,インコーポレイテッド |
嗜癖治療におけるn−アリールジアザスピラ環状化合物の使用
|
GB0428082D0
(en)
|
2004-12-22 |
2005-01-26 |
Welcome Trust The Ltd |
Therapeutic compounds
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
WO2007024814A1
(en)
|
2005-08-22 |
2007-03-01 |
Targacept, Inc. |
HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
TWI468162B
(zh)
|
2005-12-13 |
2015-01-11 |
英塞特公司 |
作為傑納斯激酶(JANUS KINASE)抑制劑之經雜芳基取代之吡咯并〔2,3-b〕吡啶及吡咯并〔2,3-b〕嘧啶
|
JP5498703B2
(ja)
|
2006-01-23 |
2014-05-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なチオフェン−カルボキサミド
|
EP2418210A1
(en)
|
2006-04-13 |
2012-02-15 |
Vertex Pharmceuticals Incorporated |
Thiophene-carboxamides useful as inhibitors of protein kinases
|
EP1849781A1
(en)
|
2006-04-28 |
2007-10-31 |
Laboratorios del Dr. Esteve S.A. |
Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments
|
CN101495474A
(zh)
|
2006-05-23 |
2009-07-29 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的噻吩-甲酰胺类
|
JP2009538309A
(ja)
|
2006-05-23 |
2009-11-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド
|
WO2008006583A1
(en)
|
2006-07-14 |
2008-01-17 |
Novartis Ag |
Pyrimidine derivatives as alk-5 inhibitors
|
US20100009969A1
(en)
|
2006-07-27 |
2010-01-14 |
Ucb Pharma, S.A. |
Fused Oxazoles & Thiazoles As Histamine H3- Receptor Ligands
|
MX2009007051A
(es)
|
2006-12-28 |
2009-07-10 |
Abbott Lab |
Inhibidores de la poli(adp-ribosa) polimerasa.
|
US8466150B2
(en)
|
2006-12-28 |
2013-06-18 |
Abbott Laboratories |
Inhibitors of poly(ADP-ribose)polymerase
|
EP2036906A1
(de)
|
2007-09-05 |
2009-03-18 |
Bayer Schering Pharma Aktiengesellschaft |
Azaindole als Inhibitoren der löslichen Adenylatzyklase
|
AR070127A1
(es)
|
2008-01-11 |
2010-03-17 |
Novartis Ag |
Pirrolo - pirimidinas y pirrolo -piridinas
|
WO2009092764A1
(en)
|
2008-01-24 |
2009-07-30 |
Ucb Pharma, S.A. |
Compounds comprising a cyclobutoxy group
|
WO2009158719A2
(en)
|
2008-06-27 |
2009-12-30 |
Hydra Biosciences, Inc. |
Methods and compositions for treating disorders
|
AU2010250055A1
(en)
|
2009-02-27 |
2011-09-15 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
EP2485589A4
(en)
|
2009-09-04 |
2013-02-06 |
Biogen Idec Inc |
HETEROARYARY INHIBITORS OF BTK
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
EP2550278A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
TW201139438A
(en)
|
2010-03-24 |
2011-11-16 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
EP2550268A1
(en)
|
2010-03-24 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
WO2011117381A1
(en)
|
2010-03-26 |
2011-09-29 |
Boehringer Ingelheim International Gmbh |
B-raf kinase inhibitors
|
JP5871897B2
(ja)
|
2010-03-26 |
2016-03-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピリジルトリアゾール
|
WO2011146401A1
(en)
|
2010-05-17 |
2011-11-24 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
LT2975042T
(lt)
|
2010-06-23 |
2019-01-25 |
Hanmi Science Co., Ltd. |
Naujieji kondensuoti pirimidino dariniai, skirti tirozino kinazės aktyvumo slopinimui
|
US8735386B2
(en)
|
2010-07-23 |
2014-05-27 |
Boehringer Ingelheim International Gmbh |
Aminopyrazoloquinazolines
|
WO2012068450A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
US8710055B2
(en)
|
2010-12-21 |
2014-04-29 |
Boehringer Ingelheim International Gmbh |
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
CA2827392A1
(en)
|
2011-02-24 |
2012-08-30 |
Emory University |
Noggin blocking compositions for ossification and methods related thereto
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
WO2012154608A1
(en)
|
2011-05-06 |
2012-11-15 |
Intellikine, Llc |
Reactive mtor and pi3 kinase inhibitors and uses thereof
|
WO2013025484A1
(en)
|
2011-08-12 |
2013-02-21 |
Lapchak Paul A |
Polyphenol analogs to treat ischemia
|
JP2014524426A
(ja)
|
2011-08-12 |
2014-09-22 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
神経保護ポリフェノールアナログ
|
CN103889982A
(zh)
|
2011-10-18 |
2014-06-25 |
先正达参股股份有限公司 |
杀微生物的吡唑衍生物
|
GB201119799D0
(en)
|
2011-11-16 |
2011-12-28 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2013078440A2
(en)
|
2011-11-23 |
2013-05-30 |
Intellikine, Llc |
Enhanced treatment regimens using mtor inhibitors
|
EP2615083A1
(en)
|
2012-01-10 |
2013-07-17 |
Studiengesellschaft Kohle mbH |
Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX2014012266A
(es)
|
2012-04-12 |
2014-12-05 |
Xenon Pharmaceuticals Inc |
Sintesis asimetricas para compuestos espiro-oxindol utiles como agentes terapeuticos.
|
JP2015520752A
(ja)
|
2012-05-11 |
2015-07-23 |
アッヴィ・インコーポレイテッド |
Nampt阻害薬としてのピリダジンおよびピリジン誘導体
|
JP2015516436A
(ja)
|
2012-05-11 |
2015-06-11 |
アッヴィ・インコーポレイテッド |
Nampt阻害薬
|
CN104271572A
(zh)
|
2012-05-11 |
2015-01-07 |
艾伯维公司 |
用作nampt抑制剂的噻唑羧酰胺衍生物
|
US9593115B2
(en)
|
2012-09-21 |
2017-03-14 |
Advinus Therapeutics Ltd. |
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
|
WO2014158943A1
(en)
|
2013-03-13 |
2014-10-02 |
Avon Products, Inc |
Tyrosinase inhibitors
|
WO2014151147A1
(en)
|
2013-03-15 |
2014-09-25 |
Intellikine, Llc |
Combination of kinase inhibitors and uses thereof
|
US20160008493A1
(en)
|
2013-03-15 |
2016-01-14 |
The Johns Hopkins University |
Radioactive substrates for aldehyde dehydrogenase
|
EP2970289A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
WO2014190096A1
(en)
|
2013-05-22 |
2014-11-27 |
Curza Global, Llc |
Compositions and methods comprising a polyamine
|
JP6619731B2
(ja)
|
2013-06-18 |
2019-12-11 |
4エスツェー アクチェンゲゼルシャフト |
Dyrkキナーゼ阻害剤としての2,3−ジヒドロベンゾフラン−5−イル化合物
|
US20160368897A1
(en)
|
2013-06-28 |
2016-12-22 |
Emory University |
Pyrazoline Dihydroquinolones, Pharmaceutical Compositions, and Uses
|
SG11201600147TA
(en)
|
2013-06-28 |
2016-02-26 |
Beigene Ltd |
Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors
|
PL3023100T3
(pl)
*
|
2013-07-18 |
2019-07-31 |
Taiho Pharmaceutical Co., Ltd. |
Lek przeciwnowotworowy do okresowego podawania inhibitora FGFR
|
US10124003B2
(en)
|
2013-07-18 |
2018-11-13 |
Taiho Pharmaceutical Co., Ltd. |
Therapeutic agent for FGFR inhibitor-resistant cancer
|
AU2014295000A1
(en)
|
2013-07-25 |
2016-02-18 |
Fondazione Telethon |
Inhibitors of FAPP2 and uses thereof
|
CN104341425B
(zh)
*
|
2013-08-08 |
2018-11-02 |
上海医药集团股份有限公司 |
氘代乙炔衍生物、其药物组合物及应用
|
EP3038618B1
(en)
|
2013-08-28 |
2020-10-14 |
Vanderbilt University |
Substituted indole mcl-1 inhibitors
|
CN104262328B
(zh)
|
2013-09-18 |
2016-09-07 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
RU2650512C2
(ru)
|
2013-09-18 |
2018-04-16 |
Бейджин Ханми Фармасьютикал Ко., Лтд. |
Соединение, ингибирующее активности киназ ВТК и/или JAK3
|
CA2931431A1
(en)
|
2013-12-05 |
2015-06-11 |
Acerta Pharma B.V. |
Therapeutic combination of a pi3k inhibitor and a btk inhibitor
|
WO2015134357A1
(en)
|
2014-03-03 |
2015-09-11 |
Emory University |
Modulators of insulin receptor
|
SG11201701169XA
(en)
|
2014-08-15 |
2017-03-30 |
Chia Tai Tianqing Pharmaceutical Group Co Ltd |
Pyrrolopyrimidine compounds used as tlr7 agonist
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
WO2016044445A2
(en)
|
2014-09-17 |
2016-03-24 |
Ironwood Pharmaceuticals, Inc. |
sGC STIMULATORS
|
CN107108512B
(zh)
|
2014-10-10 |
2021-05-04 |
基因泰克公司 |
治疗性化合物及其用途
|
EP3242874B1
(en)
|
2015-01-09 |
2018-10-31 |
Genentech, Inc. |
Pyridazinone derivatives and their use in the treatment of cancer
|
AR104020A1
(es)
|
2015-06-04 |
2017-06-21 |
Kura Oncology Inc |
Métodos y composiciones para inhibir la interacción de menina con proteínas mill
|
WO2016197027A1
(en)
|
2015-06-04 |
2016-12-08 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
US10975071B2
(en)
|
2015-09-28 |
2021-04-13 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US11476426B2
(en)
|
2016-02-03 |
2022-10-18 |
Sfc Co., Ltd. |
Organic light emitting compounds and organic light emitting devices including the same
|
CN107840842A
(zh)
|
2016-09-19 |
2018-03-27 |
北京天诚医药科技有限公司 |
炔代杂环化合物、其制备方法及其在医药学上的应用
|
EP3515914A4
(en)
|
2016-09-24 |
2020-04-15 |
BeiGene, Ltd. |
NEW IMIDAZO [1,5-A] PYRIDINES SUBSTITUTED IN POSITION 5 OR 8 AS INDOLEAMINE AND / OR TRYPTOPHANE 2,3-DIOXYGENASES
|
US10377743B2
(en)
|
2016-10-07 |
2019-08-13 |
Araxes Pharma Llc |
Inhibitors of RAS and methods of use thereof
|
US11130761B2
(en)
*
|
2016-12-29 |
2021-09-28 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors
|
WO2018140513A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
EP3573967A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused hetero-hetero bicyclic compounds and methods of use thereof
|
US20200385364A1
(en)
|
2017-01-26 |
2020-12-10 |
Araxes Pharma Llc |
Fused n-heterocyclic compounds and methods of use thereof
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
WO2018170225A1
(en)
|
2017-03-15 |
2018-09-20 |
Athenex, Inc. |
Biaryl piperidine amide compounds and methods of use thereof
|
CN108623562A
(zh)
|
2017-03-24 |
2018-10-09 |
中国海洋大学 |
一种喹啉酮生物碱类化合物及其制备方法和应用
|
CN108658974A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种内酰胺类化合物及其制备方法和用途
|
CN108658972A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种取代内酰胺类化合物及其制备方法和用途
|
CN108690016B
(zh)
|
2017-04-11 |
2022-08-12 |
广东东阳光药业有限公司 |
吡唑并吡啶类化合物及其用途
|
WO2018226976A1
(en)
|
2017-06-08 |
2018-12-13 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
WO2019023448A1
(en)
|
2017-07-26 |
2019-01-31 |
Emory University |
INHIBITORS OF NADPH OXIDASE AND THEIR USE
|
JP2020531453A
(ja)
|
2017-08-15 |
2020-11-05 |
インフレイゾーム リミテッド |
Nlrp3阻害剤としてのスルホニルウレアおよびスルホニルチオウレア
|
US20200361895A1
(en)
|
2017-08-15 |
2020-11-19 |
Inflazome Limited |
Novel sulfonamide carboxamide compounds
|
CN110117285B
(zh)
|
2018-02-07 |
2023-02-03 |
广东东阳光药业有限公司 |
流感病毒复制抑制剂及其用途
|
US20210154188A1
(en)
|
2018-04-02 |
2021-05-27 |
Silverback Therapeutics, Inc. |
Alk5 inhibitors, conjugates, and uses thereof
|
WO2019226991A1
(en)
|
2018-05-25 |
2019-11-28 |
Essa Pharma, Inc. |
Androgen receptor modulators and methods for their use
|
TW202021969A
(zh)
|
2018-05-31 |
2020-06-16 |
南韓商C&C新藥研究所 |
雜環衍生物及其用途
|
TW202016109A
(zh)
|
2018-06-13 |
2020-05-01 |
英屬開曼群島商百濟神州有限公司 |
作為hpk1抑制劑的吡咯並[2,3-b]吡啶或吡咯並[2,3-b]吡嗪及其用途
|
JP2021532157A
(ja)
|
2018-08-01 |
2021-11-25 |
アラクセス ファーマ エルエルシー |
がんを処置するための複素環式スピロ化合物およびその使用方法
|
AU2020278566A1
(en)
|
2019-05-17 |
2021-12-23 |
Kinnate Biopharma Inc. |
Inhibitors of fibroblast growth factor receptor kinases
|
BR112022024729A2
(pt)
|
2020-06-05 |
2023-02-28 |
Kinnate Biopharma Inc |
Inibidores de quinases do receptor do fator de crescimento de fibroblastos
|
CA3181209A1
(en)
|
2020-06-05 |
2021-12-09 |
Stephen W. Kaldor |
Inhibitors of fibroblast growth factor receptor kinases
|